Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2008-08-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Muscle Protein Signalling
NCT00653679
Combined Nutrient Intake and Muscle Protein Synthesis
NCT01239277
Habitual Protein Intake and Muscle Protein Synthesis
NCT01986842
Impact of Carbohydrate Co-ingestion on the Post-prandial Anabolic Response of Protein in Young and Elderly Men
NCT01576848
Protein Intake Distribution to Support Muscle Anabolism in Healthy Young Adults
NCT07245199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
carbohydrate and protein
The intake of carbohydrate and protein during endurance type exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
carbohydrate and protein
The intake of carbohydrate and protein during endurance type exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Not physically active
18 Years
28 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Milou Beelen
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
L van Loon, PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC 83017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.